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2D DIGE does not reveal all: a
scotopic report suggests differential
expression of a single “calponin
family member” protein for tetany of
sphincters!
Arun Chaudhury*
GIM Foundation, Little Rock, AR, USA
Using 2D differential gel electrophoresis (DIGE) and mass spectrometry (MS), a recent
report by Rattan and Ali (2015) compared proteome expression between tonically
contracted sphincteric smooth muscles of the internal anal sphincter (IAS), in comparison
to the adjacent rectum [rectal smooth muscles (RSM)] that contracts in a phasic fashion.
The study showed the differential expression of a single 23 kDa protein SM22, which
was 1.87 fold, overexpressed in RSM in comparison to IAS. Earlier studies have shown
differences in expression of different proteins like Rho-associated protein kinase II, myosin
light chain kinase, myosin phosphatase, and protein kinase C between IAS and RSM.
The currently employed methods, despite its high-throughput potential, failed to identify
these well-characterized differences between phasic and tonic muscles. This calls into
question the fidelity and validatory potential of the otherwise powerful technology of 2D
DIGE/MS. These discrepancies, when redressed in future studies, will evolve this recent
report as an important baseline study of “sphincter proteome.” Proteomics techniques
are currently underutilized in examining pathophysiology of hypertensive/hypotensive
disorders involving gastrointestinal sphincters, including achalasia, gastroesophageal
reflux disease (GERD), spastic pylorus, seen during diabetes or chronic chemotherapy,
intestinal pseudo-obstruction, and recto-anal incontinence. Global proteome mapping
may provide instant snapshot of the complete repertoire of differential proteins, thus expe-
diting to identify the molecular pathology of gastrointestinal motility disorders currently
labeled “idiopathic” and facilitating practice of precision medicine.
Keywords: gastrointestinal motility, inhibitory neurotransmission, smooth muscle, phasic, tonic
A recent report (1) addressed a significant but relatively unsolved area of interest to smooth muscle
physiologists. Using the advanced proteomics techniques of 2D differential gel electrophoresis
(DIGE) andmass spectrometry (MS), the study (1) examined whether differential proteome expres-
sion underlies the physiology of tonically contracted sphincteric smooth muscles of the internal
anal sphincter (IAS), in comparison to non-sphincteric muscles of the adjacent rectum (RSM, rectal
smooth muscles) that periodically contracts in a phasic fashion. The proteomic study revealed that
the 23 kDa protein SM22 is present 1.87 fold more in phasic smooth muscles in comparison to tonic
smooth muscles (1).
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SM22, also called transgelin because of its ability to gel in vitro
actin, crosslinks actin microfilaments (2). Smooth muscles are
unique in that they are able to adjust their contraction/relaxation
status by reorganizing themicrofilaments of the actin cytoskeleton
and the intermediate filament network (3). This whole hypothesis
revolves around the central rationale of an ensemble of protein
crosslinking in the cell periphery, involving myosin, actin, and
the smooth muscle cell membrane, and also potentially with the
cytoskeleton. Calponin family members of proteins, including
calponin and caldesmon, have been reported to inhibit acto-
myosin formation by blockingmyosin-binding sites on actin, thus
reducing cellular mechanical tone (4, 5). SM22 also belongs to the
protein family containing “calponin homology domains” (6).
The application of high throughput technologies to addressing
these fundamental aspects of gut sphincteric proteomic compo-
sition is a unique approach (1). Earlier, global protein profiles
of rat jejuno-ileocolic neuro-smooth muscle lysates have identi-
fied transgelin (SM22) (7). However, the somewhat incomplete
nature of the study report (1) defeats the purpose of the potential
impact of implementing a high throughput methodology to delve
into a long unanswered question. Surprisingly, previous studies
examining the proteome of other tonic muscles of the gastroin-
testinal tract, like the lower esophageal sphincter (LES), revealed
differential distribution of several proteins between the tonic LES
and the phasic esophageal body (EB) (8). For example, the EB
circular muscle demonstrated higher proportions of (i) LC17a
relative to LC17b, (ii) myosin heavy chain isoform with seven-
amino acid insert relative to the non-inserted form, (iii) γ-actin
relative to α-actin, and (iv)caldesmon (8). This study (8), however,
did not find a differential expression of SM22 between phasic and
tonic smooth muscles of the esophagus. This observation may be
explained by the possibility that there may be diverse musculo-
proteome in different gastrointestinal sphincters. However, it is
known that SM22 and its differential transcript expression is not
well-resolved in a one dimensional gel, but rather shows up in a
2D gel (9), and also has been used in the recent study (1).
Strangely, however, the report (1) lacks in completeness of cat-
aloging the complete repertoire of proteins that are differentially
expressed between the phasic and tonic smooth muscles. Only
proteins spanning 10–120 kDa are shown, and three spots corre-
sponding to SM22 expression are revealed as the only differential
proteins between phasic and tonic smoothmuscles (1). No protein
spots>120 kDa are demonstrated (1). The identity of the numer-
ous other Cy3/Cy5 and co-localized spots are not revealed (1),
leaving the reader to wonder regarding the identity of the differen-
tial protein spots. It is unlikely that SM22 is the only differentiated
protein between sphincteric and non-sphincteric regions. Earlier
studies in the IAS have revealed differential expression of numer-
ous other proteins, namely a composite of kinases/phosphatases,
including rho-associated protein kinase II (ROCKII),myosin light
chain kinase (MLCK), myosin phosphatase (MYP), and protein
kinase C (PKC) (10). These kinases and phosphatases effect a con-
tractile state of myosin with actin and microfilaments, resulting
in enhanced cellular mechanical tone (11–13). Remarkably, this
recent proteomic study (1) did not identify any of these previously
examined enzymatic key components of tone maintenance! The
readers await to visualize the datasets when the metadata of the
publicly funded study (1) are deposited in PASSEL, PRIDE, or
World2D-PAGE.
Polymeric lattice of actomyosin is present in smooth muscles,
much like in skeletal muscles, and yet contributes to differential
basal tone in the sphincteric regions. This results from preci-
sion in regulation of its association. The sphincters function as
a sluicegate for luminal flow impedance. The study (1) utilized
relatively pure cellular concentrates of IAS and RSM in culture.
This is the strength of the study. The presence of SM22 in gastroin-
testinal smooth muscles has been demonstrated earlier (7, 14).
Furthermore, ubiquitous distribution of SM22 in various kinds of
mammalian smooth muscles (vascular, uterine, urinary bladder)
has been shown (14, 15). These brings into questions of how SM22
exclusively may potentially contribute to development of smooth
muscle tone in sphincteric muscles. Three levels of evidence have
been provided regarding the differential expression of SM22: (a)
2D DIGE revealed 2.14, 1.64, and 1.82 fold changes of SM22
expression between IAS and RSM, (b) confocal volume imaging
of SM22 between IAS and RSM, and (c) quantitative Western
blotting of higher expression in the RSM in comparison to IAS (1).
The equivocal light microscopic confocal imaging showed diffuse
expression of SM22 in both IAS and RSM, and due to differences
in volume of the smooth muscles derived from two different
regions, it was not possible to decipher the staining expression per
unit voxel (1). The advanced proteomic examination, however,
revealed the subtle low level of expression of SM22 in the IAS in
comparison to RSM (1).
Normally, there are three splice variants of SM22, viz., alpha
(α), beta (β), and gamma (γ) (14). In chicken gizzard (phasic
smooth muscle), these transcripts have been reported in the ratio
of 14:5:1, whereas in vascular smooth muscles, these transcripts
are more densely present (including an additional transcript delta,
δ) (16). Pig stomach contains all four transcripts (α, β, γ, δ)
(14), whereas rabbit urinary bladder contains all the transcripts
but in different ratios (15). Likely, the three differential spots
identified for SM22 (1) represent these three variants, and thus
the fold changes of 2.14, 1.64, and 1.82 represent α, β, and γ,
respectively (α being most basic and γ most acidic forms). The
staining of SM22 has been done with polyclonal antibody (1),
which obviously could not distinguish the distribution of the
specific variants.
There may be a few possible reasons for the intriguing obser-
vation of subtle differences of SM22 between phasic and tonic
smooth muscles. First, these subtle changes could result from
differential genomic expression. This is feasible, as genomic pro-
graming delineates intermittently spaced sphincteric regions dur-
ing genesis of the gastrointestinal tracts (17). This may lead to
differential gene expression between phasic and tonic smooth
muscles. The gene contents and the heterogeneous nuclear RNAs
(hnRNASM22) may be examined by Southern and Northern blots.
A contrary argument to this possibility is that the regulation
may not occur at the gene dosage level. This possibility is also
likely because the phasic smooth muscles need to toggle back
occasionally to a tonic state of contraction, for example, during
propulsion of luminal contents. The inherent state of lower tone
than the sphincteric regions is not a rigid phenomenon but subject
to physiological variations. This situation gives rise to the second
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possibility that SM22 differential expression may be regulated at
the cytosolic level, for example, by post-transcriptional editing
of the mRNA transcripts. It is being increasingly recognized that
microRNA plays a major role in different types of muscle for-
mation. For example, DiGeorge’s syndrome related microRNA
is needed for vascular smooth muscle phenotypic differentiation
(18). Similarly,microRNAmodulates formation of cardiacmyosin
and suppresses smoothmuscle typemyosin during heart biogene-
sis (19). MicroRNA-1 has been reported to control SM22 function
(20). Whether this is the case may be derived from studies incor-
porating qRT-PCR and microRNA analysis. Furthermore, SM22
knockout mice have normal gut motility (16). In the vascular
smooth muscles, SM22 knockout results in a genetic reprogram-
ing to a chondrocytic differentiation pattern resulting in arterial
wall calcinosis (21). This may result in increased vascular tone
and hypertension. Examining the GI phenotype systematically
in SM22 knockout mice will provide valuable insights into its
function.
Nearly a century ago, the Fenn effect of dependence on
nucleotide availability to change muscle tone according to phys-
iological need was described (22). The role of post-translational
modification of SM22 by phosphorylation was tested, and was
hypothesized to preclude its protein interaction with actin in
the sphincteric smooth muscles (1). The contribution of rho-
dependent kinase (ROCK) in this phosphorylation reaction was
tested by using a specific pharmacologic inhibitor. Despite earlier
reports of increased expression of RhoA-dependent kinase in
IAS, sphincteric muscles (10), intriguingly, the 2D DIGE, how-
ever, could not identify this difference (1). Gimona et al. have
earlier demonstrated that SM22 remains unphosphorylated in
unstimulated phasic smooth muscle like the chicken gizzard, as
well as after mechanical loading and field stimulation that pro-
duces phasic contraction (9). Furthermore, in vivo SM22 remain
unphosphorylated in tonic muscle like guinea-pig tenia coli (9).
DephosphoSM22 was present in contrast to phosphorylated myosin
light chain (phosphoMLC) (9), a major biochemical change that
mediates force-generating actomyosin interaction (13). In sil-
ico analyses using KinasePhos1 shows no consensus sequence
on SM22 that is sensitive to ROCK, but rather to PKC, which
has also been earlier confirmed by in vitro analyses (6). The
temporal role of PKC and ROCK activation in LES has been
previously reported (12). The stoichiometry of particulate PKC
has been demonstrated to be lower in the IAS in comparison
to ROCK (10). The enzymatic activity of PKC in IAS has been
demonstrated in the rabbit IAS (23). Further, though relatively
different, both ROCK as well as PKC inhibitors reduce tone in
human IAS (24). The present study (1) used pharmacological
inhibition of ROCK and PKC and did not find any change of
SM22 phosphorylation with the PKC inhibitor. Additionally, the
study (1) did not examine phosphoSM22-actin binding in the co-
immunoprecipitation assays. These discrepancies merits to be
addressed in future studies. Innovative tools of actin-SM22 assays
may be incorporated, since the overlapping molecular masses
of SM22 and IgG light chains (~23 and 25 kDa, respectively)
produce confound while detecting SM22 after pull-down with
1http://kinasephos2.mbc.nctu.edu.tw/
anti-actin antibody. For example, actin antibodies developed in
alpaca that lack the immunoglobulin light chain shall help avoid
these technical limitations.
Importantly, tonic (as well as phasic) muscles in vivo are
exquisitely sensitive to cytosolic activation of cyclic GMP
(cGMP)/Protein Kinase G, resulting from inhibitory nerve-
smooth muscle nitrergic neurotransmission, and remains as the
final biochemical steps for stimulus-coupled mechanical relax-
ation2 (25–29). Interaction of cytoskeletal force moderating pro-
teins, like SM22, with the postjunctional signal transduction
machinery during basal and stimulated neurotransmission are
important areas that may be examined using imaging tools of
protein interactions like proximity ligation assay.
The SM22 promoters contain CARG boxes and GC boxes,
which are responsive to serum response factor and TGFβ (30–
32). Importantly, SM22 is also regulated by the transcription
factor “snail” (33). Recently, it has been hypothesized that snail
deregulation may contribute to the genesis of pathology involv-
ing neuromuscular apparati in diabetes mellitus (34). Whether
snail-mediated SM22 functional changes may be contributory
to gastrointestinal smooth muscle dysfunction in gastrointestinal
motility disordersmay be a significant area of future investigation.
Recent evidence suggests that neurotransmitter signals may
possess a storage form in the postjunctional cell. The signifi-
cance of these observations is far from known. For example, S-
nitrosylproteome assays show S-nitrosyl-SM22 in myometrium
of pregnant guinea-pigs. This may facilitate nitric oxide (NO)-
mediated relaxation of myometrial smooth muscles independent
of global cGMP elevation or activation of its cognate kinase,
protein kinase G type I (35). This may have tremendous impact
on the modulation of physiology of gastric emptying in preg-
nancy.Whether the present observations (1) are extensible to LES,
pylorus and ileocolic sphincter, and juxta-sphincteric regions,
shall validate the role of SM22 in esophagogastrointestinal motil-
ity and role of SM22 in specific disease pathophysiology affecting
transit of luminal contents.
Advanced proteomics shall find increasing place in investigat-
ing panoramic protein changes in hypertensive sphincters, for
example, in achalasia or gastroparesis, or hypotensive sphincters,
like the LES in gastroesophageal reflux disease (GERD) or the
pyloric sphincter in biliary reflux, or IAS in fecal incontinence
or anorectal malformations (36). The cutting-edge technologies
of advanced proteomics shall help form rationale approaches to
disorders currently labeled as “functional,” including dyspepsia,
irritable bowel syndrome (IBS), unexplained constipation, and
intestinal pseudo-obstruction (37). It should be noted that not
all gastrointestinal motility disorders manifest changes in pro-
tein expression and may involve changes in the protein function
or post-translational modification(s). For example, prejunctional
contents of neuronal nitric oxide synthase (nNOS), the enzyme
synthesizing the major inhibitory neurotransmitter NO, may
remain unaltered in select disorders of impaired gastrointestinal
smooth muscle relaxation like achalasia or diabetic gastroparesis
(38, 39). Similarly, future studies should address whether the
2http://www.nature.com/nature/report/index.html?comment=59974&doi=10.
1038/464466a
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in vitro serum-deprived culture conditions (1) resulted inmolecu-
lar plasticity of the IAS smoothmuscle cells. Calponin is known to
decrease during in vitro culture, whereas SM22 remains relatively
unaffected (9). SM22 expression is sensitive to transcriptional
agents present in the serum (32). In fact, deprivation of serum
response factors has been correlated with occurrence of chronic
intestinal pseudo-obstruction (40).
Full-thickness gastrointestinal muscular biopsies from sphinc-
teric and non-sphincteric regions are difficult to obtain for prag-
matic reasons (39). Innovative approaches are needed for routine
proteome examination of peripheral fluids or tissues and luminal
contents to correlate with actual neurotransmitter contents in the
enteric nerve terminal-smooth muscle junctions (40). All of these
aspects merit consideration while obtaining “big data” related
to chronic pathophysiology affecting gastrointestinal neuromus-
cular function. The wave of personalized medicine to redefine
the molecular pathology of the so-called “idiopathic” disorders
of gut motility will find increased clinical applications of the
high throughput proteomic techniques and contribute to a top-
down view of what lies beneath the often-unexplainable clinical
observations, thus enabling to practice precision medicine.
In summary, this current investigation (1) is timely reopening
of the Pandora’s Box, delving into mechanisms of understanding
how sphincters are formed. Because phasic muscles have the abil-
ity to produce agonist-mediated maximal contraction similar to
tonic muscles, and tonic muscles possess ability to relax to base-
lines comparable with that of phasic muscles during inhibitory
neurotransmission, the fine regulation of multiplex proteins likely
results in this complex regulation. The importance of the sub-
tle differences in the SM22 splice variants between sphincteric
and non-sphincteric regions, along with the repertoire of other
potential contributing proteins, merits detailed future study.
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